NewsBenzingaHC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target Benzinga 2026.09.29 15:43 (GMT+0) Open on Benzinga Other news Lundbeck Is Said To Express Interest In Buying Xeris Biopharma Oppenheimer Maintains Outperform on Jefferies Financial Gr, Lowers Price Target to $71 What's Going On With Nebius Group Stock Tuesday? SpaceX Stock Rises Tuesday: What's Fueling the Move? BTIG Reiterates Buy on Aldeyra Therapeutics, Maintains $9 Price Target Here's How Much $100 Invested In Johnson Controls Intl 5 Years Ago Would Be Worth Today
